Medicine guide
Duzallo
·
- Prescription status not stated
- Muscles, joints and bones
- Active substance
- Allopurinol;lesinurad
- Used in
- Muscles, joints and bones
- Made by
- Grunenthal GmbH
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Duzallo is indicated in adults for the treatment of hyperuricaemia in gout patients who have not achieved target serum uric acid levels with an adequate dose of allopurinol alone.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Grunenthal GmbH |
|---|---|
| Active substance | Allopurinol;lesinurad |
| Used in | Muscles, joints and bones |
| Classification | M04AA51 · Muscles, joints and bones |
| Additional monitoring ▼ | Yes — under additional monitoring (black triangle). Report suspected side effects. |
| Authorised on | 2018-08-23 |
| EMA product number | EMEA/H/C/004412 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).